Key result
AI-based Q-AortaECG accurately triages acute aortic syndrome with ~0.88 AUROC.
Why the study?
Delayed recognition of acute aortic syndrome can occur because presenting symptoms and ECG phenotypes overlap with ACS, pulmonary embolism, and pericarditis. Although CTA is the confirmatory standard, the 12-lead ECG is obtained earlier at triage and may carry distributed signatures useful for early AAS triage.
Does the Q-AortaECG multi-agent 12-lead ECG system improve early triage accuracy and clinician recognition of acute aortic syndrome in suspected-AAS patients?
Observational (n=1,251)
Yes
Does the Q-AortaECG multi-agent 12-lead ECG system improve early triage accuracy and clinician recognition of acute aortic syndrome in suspected-AAS patients?
Effect estimate: AUROC 0.881 (95% CI 0.852-0.908)
The Q-AortaECG 12-lead ECG decision-support system demonstrated high sensitivity (95.5%) for acute aortic syndrome, improved clinician diagnostic sensitivity from 69.6% to 87.0% without sacrificing specificity, and could potentially shorten time to diagnostic confirmation in unsuspected cases.
ECG signatures may enable earlier AAS triage; hypothesis-generating and requires prospective validation before clinical use.
Acute aortic syndrome (AAS) is a time-critical vascular emergency in which delayed recognition may occur because the presenting symptoms and electrocardiographic phenotypes often overlap with acute coronary syndrome, pulmonary embolism, pericarditis, and other emergency diagnoses. Computed tomographic angiography (CTA) remains the confirmatory standard, but the 12-lead electrocardiogram (ECG) is usually obtained earlier, is universally available at triage, and may carry distributed signatures of malperfusion, ischemia mimicry, autonomic stress, conduction delay, and hemodynamic compromise. We developed Q-AortaECG, a classically implemented quantum-inspired multi-agent ECG system that integrates multiscale waveform representations, specialist ECG agents, density-state uncertainty fusion, a variational-circuit style consensus layer, and a safety-gated multidisciplinary team-style report for early AAS triage. The system was evaluated in three suspected-AAS/CTA-evaluable cohorts comprising 1,251 patients, including 467 with CTA-, surgery-, or autopsy-confirmed AAS. Across 700 locked-test patients, Q-AortaECG achieved an area under the receiver operating characteristic curve (AUROC) of 0.881 (95% confidence interval (CI), 0.852-0.908), area under the precision-recall curve (AUPRC) of 0.743 (95% CI, 0.695-0.790), sensitivity of 0.955 (231/242; 95% CI, 0.920-0.977), specificity of 0.721 (330/458; 95% CI, 0.677-0.761), positive predictive value (PPV) of 0.643, and negative predictive value (NPV) of 0.968 at the prespecified high-sensitivity threshold. Performance remained consistent in external retrospective validation and prospective silent-run evaluation, although AUPRC decreased in the lower-prevalence prospective cohort. Ablation experiments supported the contributions of self-supervised ECG pretraining, agent specialization, density-matrix uncertainty fusion, and differential diagnosis modeling. In a counterbalanced paired reader study, Q-AortaECG assistance improved overall clinician sensitivity from 0.696 to 0.870 while preserving specificity (0.851 ver sus 0.846). In prospective silent-run analysis, counterfactual alerts would have advanced the median time to the correct diagnostic pathway from 187 to 61 minutes among initially unsuspected AAS presentations. These findings support ECG first, calibrated, safety-gated decision support as an early warning scaffold for AAS triage, while preserving CTA and expert imaging interpretation as the diagnostic standard.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) conducted an observational in Acute aortic syndrome (n=1,251). Q-AortaECG (quantum-inspired multi-agent 12-lead ECG system) vs. CTA-, surgery-, or autopsy-confirmed AAS diagnosis (and unassisted clinician reading) was evaluated on Diagnostic performance (AUROC) for detecting acute aortic syndrome across 700 locked-test patients (AUROC 0.881, 95% CI 0.852-0.908). Q-AortaECG achieved an AUROC of 0.881 (95% CI, 0.852-0.908), 95.5% sensitivity, and 72.1% specificity for early triage of acute aortic syndrome in 700 locked-test patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: